Current Seminars

13/11/2012 - 18:30 - Mobile Health Solution for Wafarin Management

  Warfarin, an anticoagulant, has been actively prescribed for over 60 years, with approximately 4 million Americans currently taking Warfarin. Despite this, there are continuous safety issues associated with Warfarin treatment as patients spend an average of only 57% to 66% of their treatment time in the narrow therapeutic range. Moreover,...

06/11/2012 - 18:30 - Life Science Software Patents: Mobile Health Product Litigation

The mobile health (mHealth) industry has experienced rapid growth in the last few years. As a result, the number of mHealth patents has steadily increased over time with over 20,000 health-related mobile applications (apps) on the market. In contrast with other sectors within the software industry, very few mHealth-related patent litigations have...

30/10/2012 - 18:30 - SPIRIT: Can a software system for tracking infection in a hospital become a “product”?

Inappropriate use of antimicrobials is a growing concern for hospitals worldwide. This has led to an increased prevalence of antimicrobial resistant organisms, a problem further exacerbated by the reduced development of novel antimicrobial therapies. Antimicrobials have been found to be inappropriately used in up to 50% of cases. The growing...

23/10/2012 - 18:30 - Myriad’s Patents on BRCA 1 & BRCA 2 for Breast Cancer: What’s all the Fuss?

BRCA 1 and 2 are genes that, when mutated, increase susceptibility to breast and ovarian cancers. Myriad Genetics claimed the rights to these genes through a series of 7 utility patents. In total 15 process and compositional claims were challenged by the Association of Molecular Biology on the grounds that Myriad Genetics was in violation of 35...

09/10/2012 - 18:30 - Challenges & Opportunity in the Pharmaceutical Industry

Tuesday, October 9, 2012, 6:30-7:30pm, Instructional Centre, Room 120. Also available via webcast. Open to the public.  Guest Speaker: Dr. Neil Maresky, VP Medical & Regulatory Affairs, AstraZeneca Canada. The Master of Biotechnology Program would like to thank AstraZeneca Canada Inc. for their continued support of this seminar...

Pages